Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$527K Sell
7,280
-107
-1% -$6.49K 0.08% 160
2026
Q1
$362K Buy
7,387
+131
+2% +$6.12K 0.06% 185
2025
Q4
$261K Buy
7,256
+738
+11% +$29.9K 0.04% 215
2025
Q3
$295K Buy
+6,518
New +$264K 0.05% 202
2022
Q2
Sell
-3,819
Closed -$295K 178
2022
Q1
$295K Buy
3,819
+259
+7% +$17.7K 0.06% 162
2021
Q4
$277K Buy
3,560
+229
+7% +$18.5K 0.05% 171
2021
Q3
$267K Sell
3,331
-37
-1% -$3.18K 0.06% 184
2021
Q2
$283K Buy
3,368
+1
+0% +$81 0.06% 170
2021
Q1
$279K Buy
+3,367
New +$280K 0.06% 169
2020
Q3
$229K Buy
+3,522
New +$228K 0.06% 166

Other funds holding CGNX

Probity Advisors's CGNX Position: Q2 2026 in Review

Probity Advisors reduced its Cognex (CGNX) stake by 1.4% in Q2 2026, selling an estimated $6.49K and leaving 7,280 shares worth $527K. The position accounts for 0.08% of the portfolio, ranked #160.

Probity Advisors first reported a position in CGNX in Q3 2020 and has held it in 10 quarters since. 653 funds tracked by Wall St. Rank hold CGNX as of Q2 2026.

  • Probity Advisors held 7,280 shares of Cognex worth $527K as of Q2 2026.
  • Probity Advisors sold 107 Cognex shares in Q2 2026, an estimated $6.49K.
  • Cognex made up 0.08% of Probity Advisors's portfolio in Q2 2026, its #160 holding.
  • Probity Advisors first reported a position in Cognex in Q3 2020 and has held it in 10 quarters since.
  • 653 funds tracked by Wall St. Rank held Cognex as of Q2 2026.

Based on Probity Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.